Time course of Graves’ orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer-Reference-Cited by-同舟云学术

Time course of Graves’ orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer

Published:2016-12 Issue:48 Volume:95 Page:e5474
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Louvet Camille,De Bellis Annamaria,Pereira Bruno,Bournaud Claire,Kelly Antony,Maqdasy Salwan,Roche Beatrice,Desbiez Francoise,Borson-Chazot Francoise,Tauveron Igor,Batisse-Lignier Marie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference38 articles.

1. Graves’ ophthalmopathy;Bartalena;N Engl J Med,2009

2. Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption;Pfeilschifter;Clin Endocrinol (Oxf,1996

3. Thyrotropin receptor transcripts in human adipose tissue;Crisp;J Clin Endocrinol Metab,1997

4. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves’ ophthalmopathy patients;Wakelkamp;Clin Endocrinol (Oxf,2003

5. Effects of thyroidectomy alone or followed by radioiodine ablation of thyroid remnants on the outcome of graves’ ophthalmopathy;Moleti;Thyroid Off J Am Thyroid Assoc,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Graves’ orbitopathy development in thyroid cancer patients: a 16-year nationwide cohort study in South Korea;Eye;2024-06-28

3. Graves’ orbitopathy development in thyroid cancer patients: A 16-year nationwide cohort study in South Korea;2023-09-22

4. Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial;Frontiers in Endocrinology;2023-06-20

5. Clinical Manifestations of Thyroid-associated Ophthalmopathy Accompanied by Thyroid Cancer;Journal of the Korean Ophthalmological Society;2022-10-15